Safer injecting education for HIV prevention within a medically supervised safer injecting facility

[1]  R. Hogg,et al.  Requiring Help Injecting Independently Predicts Incident HIV Infection Among Injection Drug Users , 2005, Journal of acquired immune deficiency syndromes.

[2]  J. Montaner,et al.  Opioid substitution and HIV/AIDS treatment and prevention , 2004, The Lancet.

[3]  J. Montaner,et al.  Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users , 2004, Harm reduction journal.

[4]  J. Montaner,et al.  Rationale for evaluating North America's first medically supervised safer-injecting facility. , 2004, The Lancet. Infectious diseases.

[5]  S. Galea,et al.  Updating the infection risk reduction hierarchy: Preventing transition into injection , 2004, Journal of Urban Health.

[6]  N. Wright,et al.  Supervised injecting centres , 2004 .

[7]  E. Wood,et al.  Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[8]  M. Schechter,et al.  Requiring Help Injecting as a Risk Factor for HIV Infection in the Vancouver Epidemic , 2003, Canadian journal of public health = Revue canadienne de sante publique.

[9]  M. Schechter,et al.  Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic , 2003, AIDS.

[10]  R. Hogg,et al.  Needle exchange and difficulty with needle access during an ongoing HIV epidemic , 2002 .

[11]  R. Hogg,et al.  Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. , 2002, AIDS.

[12]  R. Broadhead,et al.  Safer Injection Facilities in North America: Their Place in Public Policy and Health Initiatives , 2002 .

[13]  D. Vlahov,et al.  Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. , 2001, Archives of internal medicine.

[14]  P. Bacchetti,et al.  Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis , 2001, The Lancet.

[15]  D. McDonald,et al.  Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia , 2000 .

[16]  Heather Miller,et al.  Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial , 1999, The Lancet.

[17]  B. Edlin,et al.  Risk factors among IDUs who give injections to or receive injections from other drug users. , 1999, Addiction.

[18]  N. Weiss,et al.  Syringe exchange and risk of infection with hepatitis B and C viruses. , 1999, American journal of epidemiology.

[19]  D. D. Des Jarlais,et al.  Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done. , 1998, Public health reports.

[20]  Samuel R Friedman,et al.  HIV incidence among injecting drug users in New York City syringe-exchange programmes , 1996, The Lancet.